Avadel Pharmaceuticals plc (Nasdaq: AVDL) based in Dublin announced today that the Compensation Committee of its Board of Directors has granted non-statutory options to five new employees to buy a total of 165,520 ordinary shares under Avadel’s 2021 Inducement Plan. These awards were provided as a hiring incentive to the employees and comply with Nasdaq Listing Rule 5635(c)(4). The options, which have a term of ten years, will vest over four years, with 25% becoming available on each anniversary of the employees' start dates, and an additional 25% on the second, third, and fourth anniversaries. The options are governed by the terms of Avadel’s 2021 Inducement Plan approved by the Board of Directors in November 2021 as well as the conditions outlined in the award agreements.